WIF1 and osteoporosis: SFRP and WIF1 can directly interact with Wnt ligands, blocking the binding of the ligands to the receptor and inactivating the Wnt signaling pathway by regulating the transcription of downstream target genes, ultimately leading to the occurrence and progression of osteoporosis [45–47].